Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

API Manufacturing: SOP for Batch Release Authorization by QA – V 2.0

Posted on By

API Manufacturing: SOP for Batch Release Authorization by QA – V 2.0

Standard Operating Procedure for Batch Release Authorization by QA in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/185/2025
Supersedes SOP/API/185/2022
Page No. Page 1 of 16
Issue Date 14/04/2025
Effective Date 16/04/2025
Review Date 14/04/2026

1. Purpose

To define the procedure for the authorization and release of API batches by the Quality Assurance (QA) department after successful completion of manufacturing, quality control analysis, and documentation review in compliance with GMP standards.

2. Scope

This SOP applies to all manufactured and tested batches of Active Pharmaceutical Ingredients (APIs) intended for commercial release, validation, or development

within the facility. The scope includes review of batch documentation, analytical results, deviations, and release approval process.

3. Responsibilities

  • Production Department: Completes batch manufacturing, fills BMRs/BPRs, and submits them to QA.
  • QC Department: Performs analysis, records results, and issues Certificate of Analysis (CoA).
  • QA Officer/Executive: Performs line-by-line review of BMR, CoA, and related documentation.
  • QA Manager: Authorizes batch release after thorough QA review and signs the Batch Release Authorization Form.
See also  API Manufacturing: SOP for Pest Control and Monitoring Program - V 2.0

4. Accountability

The Head of Quality Assurance is accountable for ensuring that no batch is released without fulfilling all required checks, validations, and regulatory requirements.

5. Procedure

5.1 Batch Review Initiation

  1. Upon completion of batch manufacturing and QC testing, production shall submit the Batch Manufacturing Record (BMR) to QA along with:
    • Analytical raw data
    • Certificate of Analysis (CoA)
    • Deviation/incident reports (if any)
    • Cleaning records and logbooks
    • In-process control data

5.2 Documentation Review by QA

  1. QA shall review the entire BMR and attachments using the Batch Release Review Checklist (Annexure-1), verifying:
    • All steps completed as per the approved BMR
    • Signatures, dates, calculations, and observations
    • Equipment cleaning, status labels, line clearance
    • Critical process parameters (CPPs) and yields
  2. Review all deviations and confirm appropriate CAPA was implemented.
  3. Verify batch number, labeling, packaging records, and reconciliation sheets.

5.3 Review of Analytical Results

  1. Check that all required tests are performed as per the approved specification.
  2. Ensure all results are within limits and properly documented in the QC report.
  3. Confirm system suitability, standard calibration, and raw chromatographic data is available and traceable.
See also  API Manufacturing: SOP for Documentation and Yield Calculation for Solvent Recovery - V 2.0

5.4 Certificate of Analysis Verification

  1. Verify CoA includes:
    • Product name and code
    • Batch number
    • Manufacturing and retest/expiry date
    • Test specifications and results
    • Approved by QC with signature and date
  2. Compare CoA against analytical test data and ensure alignment.

5.5 Final Authorization and Release

  1. QA Manager shall:
    • Review the QA Checklist and CoA
    • Verify if all documentation is complete and GMP-compliant
    • Sign the Batch Release Authorization Form (Annexure-2)
  2. Update the Batch Release Register (Annexure-3).
  3. Inform Warehouse to update inventory and label the batch as “Released.”

5.6 Conditional Release or Rejection

  1. Conditional release is allowed only when minor documentation gaps are justified and a CAPA is in place.
  2. Rejected batches must be documented using Batch Rejection Form (Annexure-4), with investigation and disposition plan.

6. Abbreviations

  • QA: Quality Assurance
  • QC: Quality Control
  • BMR: Batch Manufacturing Record
  • CPP: Critical Process Parameters
  • CAPA: Corrective and Preventive Action
  • CoA: Certificate of Analysis

7. Documents

  1. Batch Release Review Checklist (Annexure-1)
  2. Batch Release Authorization Form (Annexure-2)
  3. Batch Release Register (Annexure-3)
  4. Batch Rejection Form (Annexure-4)
See also  API Manufacturing: SOP for Archival of QA Records and BMRs - V 2.0

8. References

  • ICH Q7 – Section 11: Batch Production and Control Records
  • 21 CFR Part 211.192 – Production Record Review
  • EU GMP Part II – Sections 5 and 6

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Batch Release Review Checklist

Parameter Status Remarks
BMR Review Completed Yes All entries verified
Analytical Data Verified Yes Consistent with CoA
Deviation Closure Yes Two minor deviations closed

Annexure-2: Batch Release Authorization Form

Product Name Batch No. QA Reviewer Authorized By Release Date
API-X API01/2504/003 Sunita Reddy QA Manager 14/04/2025

Annexure-3: Batch Release Register

Batch No. Product Release Date Status Remarks
API01/2504/003 API-X 14/04/2025 Released None

Annexure-4: Batch Rejection Form

Batch No. Reason Investigation Ref Disposition QA Approval
API02/2504/001 OOS result OOS/2025/04 Rejected QA Head

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial Version New SOP QA Head
14/04/2025 2.0 Updated format and CAPA handling GMP Alignment QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: BA-BE Studies: SOP for Run Acceptance Criteria and Review – V 2.0
Next Post: Sterile Injectable Manufacturing: SOP for Cleaning of Lyophilizers Post-Batch Processing – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version